Search

everythinglearnresearchcommunity

for

Search:↓

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Hair loss increases between July and October, possibly due to UV light, and factors like skin type, hair color, and density may affect this. Dandruff can worsen hair loss conditions.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

COVID-19 may increase hair loss due to stress and inflammation.

Hair loss causes stress and affects mental health; treatment and support needed.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

Minoxidil treatment may cause hair loss.

Patients with Telogen effluvium have higher levels of heavy metals than healthy individuals.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

Post-COVID-19 patients are at risk for hair loss.

Low zinc levels in hair and serum are linked to chronic hair loss.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Effective anesthesia strategies can help minimize hair loss in patients with telogen effluvium during surgery.

Managing telogen effluvium is challenging due to limited scientific evidence.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.